In patients with T2D who had been hospitalized for poorly controlled blood glucose, SGLT2 inhibitors nearly doubled the risk ...

Eli Lilly suit against Houston’s Empower Pharmacy is a battle over access to a multi-billion dollar market for weight loss ...

This discovery shows that a thoughtful combination of medicines can make a big difference in treating complex cases of Type 2 ...

In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This ...

SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.

Eligible participants were aged 50 and over, had a diagnosis of tT2D, and no prior history of dementia or use of ...

A large population-based study found that GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2is), two classes of ...

The ‘4S’ Pathway was designed to guide shifting needs in older adults with diabetes who are struggling with diabetes ...

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying ...

Medicaid plans often put up barriers around newer classes of diabetes medications that offer cardioprotection, according to a ...

For many years, the most commonly used medicine to treat Type 2 diabetes has been metformin. It helps keep blood sugar levels ...

For example, diuretics used to treat conditions where the body retains excess fluid, including high blood pressure, can cause ...